---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-002490"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:04:56.634356+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aprea Therapeutics updates corporate presentation (January 2026)

## Summary
- Filed updated corporate presentation as Exhibit 99.1 on January 9, 2026.
- No specific financial or operational details disclosed in the filing itself.
- Presentation content not provided; unable to extract material updates.

## SEC filing metadata
- accession: 0001104659-26-002490
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/0001104659-26-002490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/apre-20260109x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-002490
- JSON: https://secwatch.observer/filing/0001104659-26-002490.json
- Plain text: https://secwatch.observer/filing/0001104659-26-002490.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.